Taro Pharmaceutical Industries Ltd (NYSE:TARO)

148.70
Delayed Data
As of May 29
 -2.22 / -1.47%
Today’s Change
103.51
Today|||52-Week Range
173.00
+0.34%
Year-to-Date
No recent news for Taro Pharmaceutical Industries Ltd.

Today’s Trading

Previous close150.92
Today’s open150.20
Day’s range148.01 - 151.79
Volume82,058
Average volume (3 months)70,695
Market cap$6.4B
Dividend yield--
Data as of 4:05pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)+36.58%
Earnings growth (this year)+30.06%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+13.16%
P/E ratio--
Price/Sales6.47
Price/Book6.27

Competitors

 Today’s
change
Today’s
% change
IDXXIDEXX Laboratories I...-0.45-0.33%
PBYIPuma Biotechnology I...-4.60-2.30%
ICPTIntercept Pharmaceut...-0.83-0.33%
SGENSeattle Genetics Inc-0.07-0.16%
Data as of 4:14pm ET, 05/29/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$759.3M
Annual profit (last year)$360.4M
Net profit margin47.51%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Kal Sundaram
Chief Financial &
Accounting Officer, Group VP
Michael Kalb
Corporate headquarters
Haifa Bay, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers